Better skin in the sun
A sunscreen SPF50+ formulation developed to support sun-damaged skin, activated by daylight and supported by independent clinical investigation.


Three effects in one product
Protects
High UV protection of SPF 50+. This prevents further damage to the skin.
Renewal-related mechanisms
Preliminary clinical evaluation explores the formulation’s interaction with skin renewal-related processes.

Structural parameters
Favorable trends have been observed in investigator-assessed skin structural parameters in exploratory analyses.
Clinical research status
An independent, double-blinded, randomized clinical study (n = 80, three months, ethically approved) observed favorable trends in investigator-assessed skin parameters.
Favorable trends observed in study
- Actinick keratosis severity
- Skin elasticity
- Skin thickness
- In subject-reported assessments, the investigational product was preferred over the control formulation


The people bringing science to life
The 3SKIN founders are pioneers in the field of photodynamic therapy (PDT) and ALA, with more than 85 years of combined experience in the clinical treatment and scientific research of skin cancer.

Built for licensing partnerships
3SKIN develops and owns the patented technology and licenses its
ground breaking product to qualified partners within skincare and sun protection.
